Author

Troy Nations

Texas Tech University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Balakrishna KoneruiD· 2 shared Danielle Evé LevittiD· 1 shared Indrajit SrivastavaiD· 1 shared Katherine E. Baillie· 1 shared Mahenour Megahed· 1 shared Md Hasnat Rashid· 1 shared Moin Uddin MarufiD· 1 shared Peter C. StirlingiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Balakrishna KoneruORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Biomineralized Surface-Enhanced Raman Scattering Nanotags Encode Biomolecular Identity into Machine Learning-Resolvable Plasmonic Fingerprints

Md Hasnat Rashid, Moin Uddin Maruf, Troy Nations, Mahenour Megahed, Danielle Evé Levitt, Balakrishna Koneru, Zeeshan Ahmad, Indrajit Srivastava

This paper develops biomineralized SERS nanotags that encode biomolecular identity into machine learning-resolvable plasmonic fingerprints for diagnostic applications.

bioRxiv · May 25, 2026 · PreprintBioengineering

DNA2 variant analysis supports the nuclease activity as a preferred therapeutic target

Katherine E. Baillie, Sijie Zhang, Veena Mathew, Troy Nations, Balakrishna Koneru, Peter C. Stirling

The paper identifies DNA2 nuclease activity as a preferred therapeutic target in cancer by showing its essential role in DNA repair and fitness, with specific sensitivity in ALT+ tumors.

bioRxiv · Jan 7, 2026 · PreprintCell Biology